Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Evaluation of the humoral response to the third dose of SARS-COV-2 vaccines in liver transplant recipients.
Ducasa N, Benencio P, Mauro E, Anders M, Mazzitelli B, Bleichmar L, Quiroga MF, Barbero M, Cairo F, Alter A, Etcheves P, Scarton G, Sobenko N, Biglione M, Mendizabal M. Ducasa N, et al. Among authors: quiroga mf. Vaccine. 2023 Dec 18;41(52):7663-7670. doi: 10.1016/j.vaccine.2023.11.039. Epub 2023 Nov 25. Vaccine. 2023. PMID: 38007341 Free article.
Humoral and T Cell Response to SARS-CoV-2 Vaccination in Patients With Rheumatoid Arthritis.
Isnardi CA, Landi M, Cruces L, Maid P, Calle Montoro C, Alfaro MA, Roldán BM, Gómez Vara AB, Giorgis P, Ezquer RA, Crespo Rocha MG, Reyes Gómez CR, Correa MÁ, Cerda OL, Rosemffet MG, Carrizo Abarza V, Catalan Pellet S, Perandones M, Reimundes C, Longueira Y, Turk G, Quiroga MF, Laufer N, De La Vega MC, Citera G, Pons-Estel GJ, Schneeberger EE. Isnardi CA, et al. Among authors: quiroga mf. Arthritis Care Res (Hoboken). 2024 Jan;76(1):120-130. doi: 10.1002/acr.25221. Epub 2023 Dec 20. Arthritis Care Res (Hoboken). 2024. PMID: 37605835
Immune Response to SARS-CoV-2 Third Vaccine in Patients With Rheumatoid Arthritis Who Had No Seroconversion After Primary 2-Dose Regimen With Inactivated or Vector-Based Vaccines.
Isnardi CA, Cerda OL, Landi M, Cruces L, Schneeberger EE, Montoro CC, Alfaro MA, Roldán BM, Gómez Vara AB, Giorgis P, Ezquer RA, Crespo Rocha MG, Reyes Gómez CR, de Los Ángeles Correa M, Rosemffet MG, Abarza VC, Pellet SC, Perandones M, Reimundes C, Longueira Y, Turk G, Quiroga MF, Laufer N, Quintana R, de la Vega MC, Kreplak N, Pifano M, Maid P, Pons-Estel GJ, Citera G. Isnardi CA, et al. Among authors: quiroga mf. J Rheumatol. 2022 Dec;49(12):1385-1389. doi: 10.3899/jrheum.220469. Epub 2022 Oct 1. J Rheumatol. 2022. PMID: 36182107 Free article.
SARS-CoV-2 humoral and cellular immune responses in COVID-19 convalescent individuals with HIV.
Giannone D, Vecchione MB, Czernikier A, Polo ML, Gonzalez Polo V, Cruces L, Ghiglione Y, Balinotti S; BBEI working group; Longueira Y, Turk G, Laufer N, Quiroga MF. Giannone D, et al. Among authors: quiroga mf. J Infect. 2022 Sep;85(3):334-363. doi: 10.1016/j.jinf.2022.05.026. Epub 2022 May 27. J Infect. 2022. PMID: 35636532 Free PMC article. No abstract available.
Increased risk of false-positive HIV ELISA results after COVID-19.
Alfie LG, Longueira YS, Pippo M, Cruces L, Quiroga MF, Turk G, Laufer N. Alfie LG, et al. Among authors: quiroga mf. AIDS. 2023 May 1;37(6):947-950. doi: 10.1097/QAD.0000000000003507. Epub 2023 Feb 7. AIDS. 2023. PMID: 36779499 Free PMC article.
COVID-19 Vaccination Responses with Different Vaccine Platforms in Patients with Inborn Errors of Immunity.
Erra L, Uriarte I, Colado A, Paolini MV, Seminario G, Fernández JB, Tau L, Bernatowiez J, Moreira I, Vishnopolska S, Rumbo M, Cassarino C, Vijoditz G, López AL, Curciarello R, Rodríguez D, Rizzo G, Ferreyra M, Ferreyra Mufarregue LR, Badano MN, Pérez Millán MI, Quiroga MF, Baré P, Ibañez I, Pozner R, Borge M, Docena G, Bezrodnik L, Almejun MB. Erra L, et al. Among authors: quiroga mf. J Clin Immunol. 2023 Feb;43(2):271-285. doi: 10.1007/s10875-022-01382-7. Epub 2022 Oct 17. J Clin Immunol. 2023. PMID: 36251205 Free PMC article.
Markers of Natural Killer Cell Exhaustion in HIV/HCV Coinfection and Their Dynamics After HCV Clearance Mediated by Direct-Acting Antivirals.
Osegueda A, Polo ML, Baquero L, Urioste A, Ghiglione Y, Paz S, Poblete G, Gonzalez Polo V, Turk G, Quiroga MF, Laufer N. Osegueda A, et al. Among authors: quiroga mf. Open Forum Infect Dis. 2023 Nov 22;10(12):ofad591. doi: 10.1093/ofid/ofad591. eCollection 2023 Dec. Open Forum Infect Dis. 2023. PMID: 38107019 Free PMC article.
39 results